Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Duke University |
---|---|
Information provided by: | Duke University |
ClinicalTrials.gov Identifier: | NCT00239525 |
The purpose of this study is to investigate real time 3-D ultrasound imaging of the brain for the diagnosis and evaluation of stroke.
Condition | Intervention | Phase |
---|---|---|
Cerebrovascular Accident, Intracranial Hypertension |
Device: 3-D ultrasound scanner Drug: Perflutren Protein-Type A Microspheres for injection |
Phase I |
Study Type: | Interventional |
Study Design: | Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Danielle R Duckworth, BSN | (919)668-1429 | danielle.duckworth@duke.edu |
United States, North Carolina | |
Duke University Medical Center | |
Durham, North Carolina, United States, 27710 |
Principal Investigator: | Daniel T Laskowitz, MD | unaffiliated |
Study ID Numbers: | 05-OPT-002 |
Study First Received: | October 13, 2005 |
Last Updated: | October 13, 2005 |
ClinicalTrials.gov Identifier: | NCT00239525 |
Health Authority: | United States: Department of Health and Human Services; United States: Office of Human Resource Protections |
Cerebral Infarction Stroke Pseudotumor Cerebri Vascular Diseases Central Nervous System Diseases Ischemia Brain Diseases |
Cerebrovascular Disorders Intracranial Hypertension Pseudotumor cerebri Brain Ischemia Brain Infarction Infarction Hypertension |
Nervous System Diseases Cardiovascular Diseases |